ACADIA Pharmaceuticals Inc (ACAD) Insider Trading
- $578,210,290.42
- $97,148,123.68
- Nov. 19, 2024
- Stephen Davis
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 30, 2020 | EVP | 1,072 | $49.22 | Sell | $52,763.84 | |
April 30, 2020 | CEO | 6,770 | $49.21 | Sell | $333,151.70 | |
April 29, 2020 | CFO | 10,000 | $50.74 | Sell | $507,400.00 | |
April 22, 2020 | President | 54,019 | $50.02 | Sell | $2,702,030.38 | |
April 20, 2020 | President | 100,000 | $50.15 | Sell | $5,015,000.00 | |
March 18, 2020 | Director | 1,050,000 | $33.30 | Buy | $34,965,000.00 | |
March 16, 2020 | Director | 694,303 | $31.51 | Buy | $21,877,487.53 | |
Jan. 7, 2020 | Director | 10,000 | $42.19 | Sell | $421,900.00 | |
Dec. 12, 2019 | EVP | 105,479 | $44.46 | Sell | $4,689,596.34 | |
Dec. 9, 2019 | CFO | 36,000 | $49.66 | Sell | $1,787,760.00 | |
Dec. 9, 2019 | EVP | 14,521 | $50.46 | Sell | $732,729.66 | |
Dec. 5, 2019 | CEO | 150,000 | $52.34 | Sell | $7,851,000.00 | |
Nov. 19, 2019 | President | 2,160 | $46.41 | Sell | $100,245.60 | |
Oct. 15, 2019 | CEO | 2,983 | $39.65 | Sell | $118,275.95 | |
Oct. 15, 2019 | Insider | 147 | $39.65 | Sell | $5,828.55 | |
Oct. 15, 2019 | EVP | 877 | $39.65 | Sell | $34,773.05 | |
Oct. 15, 2019 | President | 1,031 | $39.65 | Sell | $40,879.15 | |
Oct. 9, 2019 | CEO | 29,792 | $40.00 | Sell | $1,191,680.00 | |
Sept. 20, 2019 | Director | 1,562,500 | $40.00 | Buy | $62,500,000.00 | |
Sept. 11, 2019 | Insider | 4,645 | $41.18 | Sell | $191,281.10 | |
Sept. 9, 2019 | Director | 30,000 | $37.80 | Sell | $1,134,000.00 | |
Sept. 9, 2019 | Insider | 28,467 | $39.49 | Sell | $1,124,161.83 | |
Jan. 9, 2019 | Director | 10,000 | $20.00 | Sell | $200,000.00 | |
Nov. 30, 2018 | Director | 11,764,705 | $17.00 | Buy | $199,999,985.00 | |
Sept. 20, 2018 | Director | 1,210,776 | $18.70 | Buy | $22,641,511.20 | |
March 1, 2018 | Director | 7,000 | $23.91 | Buy | $167,370.00 | |
Jan. 29, 2018 | EVP | 36,558 | $32.39 | Sell | $1,184,113.62 | |
Jan. 2, 2018 | EVP | 74,321 | $30.14 | Sell | $2,240,034.94 | |
Jan. 2, 2018 | Director | 25,000 | $30.06 | Sell | $751,500.00 | |
Oct. 5, 2017 | EVP | 37,500 | $40.91 | Sell | $1,534,125.00 | |
Aug. 30, 2017 | EVP | 26,507 | $34.87 | Sell | $924,299.09 | |
Aug. 9, 2017 | EVP | 14,322 | $34.88 | Sell | $499,551.36 | |
July 20, 2017 | EVP | 38,097 | $30.00 | Sell | $1,142,910.00 | |
June 22, 2017 | EVP | 1,903 | $30.00 | Sell | $57,090.00 | |
Feb. 16, 2017 | EVP | 157,540 | $39.77 | Sell | $6,265,365.80 | |
Dec. 27, 2016 | EVP | 9,800 | $30.46 | Sell | $298,508.00 | |
Dec. 20, 2016 | EVP | 10,000 | $30.00 | Sell | $300,000.00 | |
Aug. 16, 2016 | Director | 1,000 | $32.97 | Buy | $32,970.00 | |
Aug. 10, 2016 | Director | 1,303,030 | $33.00 | Buy | $42,999,990.00 | |
July 12, 2016 | EVP | 16,000 | $35.00 | Sell | $560,000.00 | |
July 11, 2016 | EVP | 4,057 | $35.00 | Sell | $141,995.00 | |
April 18, 2016 | Director | 33,697 | $33.53 | Sell | $1,129,860.41 | |
April 1, 2016 | Director | 1,449,090 | $27.08 | Buy | $39,241,357.20 | |
Jan. 7, 2016 | Director | 2,586,206 | $29.00 | Buy | $74,999,974.00 | |
Nov. 11, 2015 | Director | 30,000 | $36.01 | Sell | $1,080,300.00 | |
Jan. 15, 2015 | Director | 27,973 | $33.02 | Sell | $923,668.46 | |
Jan. 14, 2015 | CEO | 30,000 | $33.98 | Sell | $1,019,400.00 | |
Dec. 15, 2014 | Director | 12,250 | $31.74 | Sell | $388,815.00 | |
Dec. 15, 2014 | CEO | 30,000 | $31.00 | Sell | $930,000.00 | |
Nov. 26, 2014 | Director | 15,000 | $30.05 | Sell | $450,750.00 |
Insiders are both buying and selling ACADIA Pharmaceuticals Inc stock.
The insider traders at ACADIA Pharmaceuticals Inc are: Stephen Davis, Srdjan R Stankovic, Brendan Teehan, James Kihara, Glenn Baity, Mark C Schneyer, Uli Hacksell, Austin D Kim, Bros. Advisors Lp Baker, Laura Brege, Elena Ridloff, Michael J Yang, Torsten Rasmussen, William Mcdowall Wells, Eric Alejandro Miller, Austin D. Kim, Mary Ann Gray, Michael T Borer, Roger Mills, James M Daly, Felix Baker, Thomas Aasen, Thomas H Aasen, Lester Ph Kaplan, Srdjan R. Stankovic, L.P. 14159, Leslie L. Iversen, Edmund Harrigan, Leslie L Iversen, Michael J. Yang, Terrence O. Moore, and Daniel B Soland
The most active insider trader at ACADIA Pharmaceuticals Inc is Stephen Davis with 26 trades.
Stephen Davis has sold the most ACADIA Pharmaceuticals Inc stock with a total value of $23,353,349.94.
Bros. Advisors Lp Baker has bought the most ACADIA Pharmaceuticals Inc stock with a total value of $449,849,410.39.
The most recent insider trade for ACADIA Pharmaceuticals Inc was on Nov. 19, 2024.
The single biggest insider buy for ACADIA Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $199,999,985.00 on Nov. 30, 2018.
The single biggest insider sell for ACADIA Pharmaceuticals Inc was from Stephen Davis with a total value of $7,851,000.00 on Dec. 5, 2019.